AirSeal CardioVascular
What is AirSeal CardioVascular?
AirSeal CardioVascular is a medical diagnostic company revolutionizing the diagnosis and management of peripheral arterial disease (PAD) and other cardiovascular conditions.
Company Leadership
Mohamed Zayed, MD, PhD, MBA
Co-Founder & CEO
Dr. Zayed is a surgeon-scientist, serial inventor and entrepreneur, and discovered the cFAS assay technology. He routinely manages patients at Barnes Jewish Hospital and Veterans Affairs and leads an NIH-funded research laboratory at WashU Medical School.
Connect on LinkedIn
Stephen Wu, PhD, MBA
Co-Founder & Chief Medical Officer
Dr. Wu is trained as a bioengineer. He has extensive industry experience in health care and biotechnology through professional occupations in manufacturing, product development, and market analysis across major biotech and health care companies.
Connect on LinkedIn
Richard Clark
CEO
Mr. Clark has over 40 years of life science innovation leadership and entrepreneurial experience with start-ups and major corporations (Medtronic, Genentech). He has two successful exits and joined AirSeal from BioGenerator EIR program.
Connect on LinkedIn